{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:21:36Z","timestamp":1776176496975,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1745-6215-10-28","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T06:16:37Z","timestamp":1241244997000},"source":"Crossref","is-referenced-by-count":26,"title":["Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices"],"prefix":"10.1186","volume":"10","author":[{"given":"Anthony J","family":"Avery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A","family":"Cantrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin J","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"key":"316_CR1","volume-title":"An organisation with a memory: report of an expert group on learning from adverse events in the NHS","author":"Department of Health","year":"2000","unstructured":"Department of Health: An organisation with a memory: report of an expert group on learning from adverse events in the NHS. 2000, London: Department of Health"},{"key":"316_CR2","volume-title":"To err is human-building a safer health system","author":"L Kohn","year":"1999","unstructured":"Kohn L, Corrigan J, Donaldson M: To err is human-building a safer health system. 1999, Washington DC: Committee on Quality of Health Care in America, Institute of Medicine"},{"key":"316_CR3","volume-title":"Building a safer NHS for patients: implementing an organisation with a memory","author":"Department of Health","year":"2000","unstructured":"Department of Health: Building a safer NHS for patients: implementing an organisation with a memory. 2000, London: Department of Health"},{"key":"316_CR4","volume-title":"Building a safer NHS for patients: improving medication safety","author":"J Smith","year":"2004","unstructured":"Smith J: Building a safer NHS for patients: improving medication safety. 2004, London: Department of Health"},{"key":"316_CR5","unstructured":"The National Coordinating Council for Medication Error Reporting and Prevention. (Accessed 10th March 2004), http:\/\/www.nccmerp.org"},{"key":"316_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/bmj.320.7237.768","volume":"320","author":"J Reason","year":"2000","unstructured":"Reason J: Human error: models and management. BMJ. 2000, 320: 768-770. 10.1136\/bmj.320.7237.768.","journal-title":"BMJ"},{"key":"316_CR7","first-page":"S17","volume":"52","author":"AJ Avery","year":"2002","unstructured":"Avery AJ, Sheikh A, Hurwitz B, Smeaton L, Chen Y-F, Howard RL, Cantrill J, Royal S: Safer medicines management in primary care. Br J Gen Pract. 2002, 52: S17-S22.","journal-title":"Br J Gen Pract"},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/qshc.2004.012153","volume":"15","author":"S Royal","year":"2006","unstructured":"Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh AI: Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006, 15: 23-31. 10.1136\/qshc.2004.012153.","journal-title":"Qual Saf Health Care"},{"key":"316_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"RL Howard","year":"2007","unstructured":"Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M: Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007, 63: 136-147. 10.1111\/j.1365-2125.2006.02698.x.","journal-title":"Br J Clin Pharmacol"},{"key":"316_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/qhc.12.4.280","volume":"12","author":"RL Howard","year":"2003","unstructured":"Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003, 12: 280-285. 10.1136\/qhc.12.4.280.","journal-title":"Qual Saf Health Care"},{"issue":"Suppl 1","key":"316_CR11","first-page":"S53","volume":"10","author":"YF Chen","year":"2001","unstructured":"Chen YF, Avery A, Neil K, Johnson C: Assessing the Occurrence and Preventability of prescribing potentially hazardous\/contraindicated drug combinations in general (family) practice. Pharmacoepidemiol Drug Saf. 2001, 10 (Suppl 1): S53-","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"316_CR12","first-page":"860","volume":"267","author":"SN Shah","year":"2001","unstructured":"Shah SN, Aslam M, Avery AJ: A survey of prescription errors in general practice. Pharm J. 2001, 267: 860-862.","journal-title":"Pharm J"},{"key":"316_CR13","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2003","unstructured":"Joint Formulary Committee: British National Formulary. 2003, London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 46","edition":"46"},{"key":"316_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","volume":"274","author":"LL Leape","year":"1995","unstructured":"Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G: Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995, 274: 35-43. 10.1001\/jama.274.1.35.","journal-title":"JAMA"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(02)08350-2","volume":"359","author":"B Dean","year":"2002","unstructured":"Dean B, Schachter M, Vincent C, Barber N: Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002, 359: 1373-1378. 10.1016\/S0140-6736(02)08350-2.","journal-title":"Lancet"},{"key":"316_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW: Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003, 289: 1107-1116. 10.1001\/jama.289.9.1107.","journal-title":"JAMA"},{"key":"316_CR17","unstructured":"MIQUEST Morbidity Information Query and Export. http:\/\/www.connectingforhealth.nhs.uk\/systemsandservices\/data\/miquest"},{"key":"316_CR18","first-page":"682","volume":"271","author":"CJ Morris","year":"2003","unstructured":"Morris CJ, Cantrill JA, Bate JR: How the use of preventable drug-related morbidity indicators can improve medicines management in primary care. Pharm J. 2003, 271: 682-686.","journal-title":"Pharm J"},{"key":"316_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/qshc.2003.008334","volume":"13","author":"CJ Morris","year":"2004","unstructured":"Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA: Indicators for preventable drug related morbidity: application in primary care. Qual Saf Health Care. 2004, 13: 181-185. 10.1136\/qshc.2003.008334.","journal-title":"Qual Saf Health Care"},{"key":"316_CR20","volume-title":"MRC's framework for the development and evaluation of RCT's for complex interventions","author":"Medical Research Council","year":"2000","unstructured":"Medical Research Council: MRC's framework for the development and evaluation of RCT's for complex interventions. 2000, London: Medical Research Council, http:\/\/www.mrc.ac.uk"},{"key":"316_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jama.1990.03440040088034","volume":"263","author":"SB Soumerai","year":"1990","unstructured":"Soumerai SB, Avorn J: Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990, 263: 549-556. 10.1001\/jama.263.4.549.","journal-title":"JAMA"},{"key":"316_CR22","volume-title":"Making healthcare safer: A critical analysis of patient safety practices Evidence report number 43","author":"H Wald","year":"2001","unstructured":"Wald H, Shojania KG: Root cause analysis. Making healthcare safer: A critical analysis of patient safety practices Evidence report number 43. 2001, Rockville, MD: Agency for Healthcare Research and Quality"},{"key":"316_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5694\/j.1326-5377.1999.tb127846.x","volume":"170","author":"FW May","year":"1999","unstructured":"May FW, Rowett DS, Gilbert AL, McNeece JI, Hurley E: Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust. 1999, 170: 471-474.","journal-title":"Med J Aust"},{"key":"316_CR24","first-page":"290","volume":"52","author":"N Freemantle","year":"2002","unstructured":"Freemantle N, Nazareth I, Eccles M, Wood J, Haines A: A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract. 2002, 52: 290-295.","journal-title":"Br J Gen Pract"},{"key":"316_CR25","unstructured":"Methotrexate IT requirement specification. http:\/\/www.npsa.nhs.uk\/nrls\/alerts-and-directives\/alerts\/oral-methotrexate\/"},{"key":"316_CR26","volume-title":"Los Angeles: CA","author":"JD Elashoff","year":"2005","unstructured":"Elashoff JD: nQuery Advisor\u00aeVersion 6.0 Software. Los Angeles: CA. 2005"},{"key":"316_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/bmj.316.7142.1455","volume":"316","author":"SM Kerry","year":"1998","unstructured":"Kerry SM, Bland JM: Statistics notes: The intracluster correlation coefficient in cluster randomisation. BMJ. 1998, 316: 1455-1460.","journal-title":"BMJ"},{"key":"316_CR28","volume-title":"Audit and feedback: effects on professional practice and health care outcomes","author":"G Jamtvedt","year":"2004","unstructured":"Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD: Audit and feedback: effects on professional practice and health care outcomes. 2004, Chichester, UK: The Cochrane Library"},{"key":"316_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0002-9343(97)89519-8","volume":"100","author":"JT Hanlon","year":"1996","unstructured":"Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR: A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996, 100: 428-437. 10.1016\/S0002-9343(97)89519-8.","journal-title":"Am J Med"},{"key":"316_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1211\/096176702776868451","volume":"10","author":"A Fish","year":"2002","unstructured":"Fish A, Watson MC, Bond CM: Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 2002, 10: 225-233. 10.1211\/096176702776868451.","journal-title":"Int J Pharm Pract"},{"key":"316_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.2042-7174.1999.tb00978.x","volume":"7","author":"AG Gran\u00e5s","year":"1999","unstructured":"Gran\u00e5s AG, Bates I: The effect of pharmaceutical review of repeat prescriptions in general practice. Int J Pharm Pract. 1999, 7: 264-275.","journal-title":"Int J Pharm Pract"},{"key":"316_CR32","first-page":"R7","volume":"263","author":"CA Mackie","year":"1999","unstructured":"Mackie CA, Lawson DH, Campbell A, Maclaren AG, Waigh R: A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J. 1999, 263: R7-","journal-title":"Pharm J"},{"key":"316_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ageing\/30.3.205","volume":"30","author":"J Krska","year":"2001","unstructured":"Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G: Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001, 30: 205-211. 10.1093\/ageing\/30.3.205.","journal-title":"Age Ageing"},{"key":"316_CR34","unstructured":"Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL: Educational outreach visits: Effects on professional practice and health care outcomes (Cochrane review). The Cochrane Library. 2004, Chichester, UK: John Wiley & Sons Ltd, 1"},{"key":"316_CR35","doi-asserted-by":"publisher","first-page":"II-2","DOI":"10.1097\/00005650-200108002-00002","volume":"39","author":"JM Grimshaw","year":"2001","unstructured":"Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA: Changing Provider Behavior: An Overview of Systematic Reviews of Interventions. Med Care. 2001, 39: II-2-II-45. 10.1097\/00005650-200108002-00002.","journal-title":"Med Care"},{"key":"316_CR36","unstructured":"Department of Communities and Local Government. Indices of Deprivation 2004. http:\/\/www.communities.gov.uk\/archived\/general-content\/communities\/indicesofdeprivation\/216309\/"},{"key":"316_CR37","unstructured":"Quality and Outcomes Framework (QOF). (accessed 16 Feburary 2009), http:\/\/www.dh.gov.uk\/en\/Healthcare\/Primarycare\/Primarycarecontracting\/QOF\/index.htm"},{"key":"316_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","volume":"355","author":"SF Assmann","year":"2000","unstructured":"Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016\/S0140-6736(00)02039-0.","journal-title":"Lancet"},{"key":"316_CR39","volume-title":"Health Technology Assessment","author":"OC Ukoumunne","year":"1999","unstructured":"Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ: Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment. 1999, 3: doi:10.3310\/hta3050"},{"key":"316_CR40","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/sim.1296","volume":"21","author":"SJ Pocock","year":"2002","unstructured":"Pocock SJ, Assmann SE, Enos LE, Kasten LE: Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002, 21: 2917-2930. 10.1002\/sim.1296.","journal-title":"Stat Med"},{"key":"316_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jclinepi.2003.09.014","volume":"57","author":"AV Hern\u00e1ndez","year":"2004","unstructured":"Hern\u00e1ndez AV, Steyerberg EW, Habbema JD: Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004, 57: 454-460. 10.1016\/j.jclinepi.2003.09.014.","journal-title":"J Clin Epidemiol"},{"key":"316_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0197-2456(97)00147-5","volume":"19","author":"WW Hauck","year":"1998","unstructured":"Hauck WW, Anderson S, Marcus SM: Should we adjust for covariates in nonlinear regression analyses of randomized trials?. Control Clin Trials. 1998, 19: 249-256. 10.1016\/S0197-2456(97)00147-5.","journal-title":"Control Clin Trials"},{"key":"316_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S Hollis","year":"1999","unstructured":"Hollis S, Campbell F: What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999, 319: 670-674.","journal-title":"BMJ"},{"key":"316_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1468-6708-3-4","volume":"3","author":"WJ Shih","year":"2002","unstructured":"Shih WJ: Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med. 2002, 3: 4-10.1186\/1468-6708-3-4.","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"316_CR45","volume-title":"Special Edition Release 10.1 edition","author":"StataCorp LP","year":"2008","unstructured":"StataCorp LP: Stata data analysis and statistical Software. Special Edition Release 10.1 edition. 2008, College Station, Texas: Stata"},{"key":"316_CR46","volume-title":"Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling","author":"TAB Snijders","year":"1999","unstructured":"Snijders TAB, Bosker RJ: Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 1999, London: Sage Publications Ltd"},{"key":"316_CR47","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"M Drummond","year":"2005","unstructured":"Drummond M, MJ S, Torrance G, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2005, Oxford: Oxford University Press, 3","edition":"3"},{"key":"316_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/S0266462305050531","volume":"21","author":"TN Flynn","year":"2005","unstructured":"Flynn TN, Peters TJ: Cluster randomized trials: Another problem for cost-effectiveness ratios. International Journal of Technology Assessment in Health Care. 2005, 21: 403-409. 10.1017\/S0266462305050531.","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"316_CR49","unstructured":"Netten A, Dennett J, (Eds): Unit costs of community care 2007. 2007, Kent, Canterbury: Personal Social Services Research Unit"},{"key":"316_CR50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/135581969800300410","volume":"3","author":"A Briggs","year":"1998","unstructured":"Briggs A, Gray A: The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998, 3: 233-245.","journal-title":"J Health Serv Res Policy"},{"key":"316_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","volume":"3","author":"BA van Hout","year":"1994","unstructured":"van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C\/E-ratios alongside a clinical trial. Health Econ. 1994, 3: 309-319. 10.1002\/hec.4730030505.","journal-title":"Health Econ"},{"key":"316_CR52","unstructured":"World Medical Association Declaration of Helsinki. http:\/\/www.wma.net\/e\/policy\/b3.htm"},{"key":"316_CR53","unstructured":"European Union Commission Directive 2005\/28\/EC. http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2005:091:0013:0019:EN:PDF"}],"updated-by":[{"DOI":"10.1186\/1745-6215-11-23","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T00:00:00Z","timestamp":1267488000000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-10-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T02:53:26Z","timestamp":1710298406000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-10-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-10-28","relation":{"erratum":[{"id-type":"doi","id":"10.1186\/1745-6215-11-23","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]},"article-number":"28"}}